Structural modification aimed for improving solubility of lead compounds in early phase drug discovery

B Das, ATK Baidya, AT Mathew, AK Yadav… - Bioorganic & Medicinal …, 2022 - Elsevier
Many lead compounds fail to reach clinical trials despite being potent because of low
bioavailability attributed to their insufficient solubility making solubility a primary and crucial …

Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities

X Jiang, K Wu, R Bai, P Zhang, Y Zhang - European Journal of Medicinal …, 2022 - Elsevier
Quinoxalinones are a class of heterocyclic compounds which attract extensive attention
owing to their potential in the field of organic synthesis and medicinal chemistry. During the …

AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future

MS Bowers, BT Chen, A Bonci - Neuron, 2010 - cell.com
Experience-dependent plasticity at excitatory synapses of the mesocorticolimbic system is a
fundamental brain mechanism that enables adaptation to an ever-changing environment …

The road map to oral bioavailability: an industrial perspective

VH Thomas, S Bhattachar, L Hitchingham… - Expert opinion on …, 2006 - Taylor & Francis
Optimisation of oral bioavailability is a continuing challenge for the pharmaceutical and
biotechnology industries. The number of potential drug candidates requiring invivo …

PIII/PV=O Catalyzed Cascade Synthesis of N‐Functionalized Azaheterocycles

TV Nykaza, G Li, J Yang, MR Luzung… - Angewandte Chemie …, 2020 - Wiley Online Library
An organocatalytic method for the modular synthesis of diverse N‐aryl and N‐alkyl
azaheterocycles (indoles, oxindoles, benzimidazoles, and quinoxalinediones) is reported …

Quinoxalines, Volume 61, Spplement 2

DJ Brown, EC Taylor, JA Ellman - 2004 - books.google.com
This volume in the Chemistry of Heterocyclic Compounds series presents a comprehensive
review of the quinoxaline literature from 1975 to the present (2002), updating Volumes 5 and …

Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines

R Tandon, I Singh, V Luxami, N Tandon… - The Chemical …, 2019 - Wiley Online Library
Besides worthy development in cancer therapy, cancer is still one of the leading causes of
death, worldwide. The future burden of cancer will probably be even larger because people …

Competitive AMPA receptor antagonists

D Catarzi, V Colotta, F Varano - Medicinal research reviews, 2007 - Wiley Online Library
Glutamic acid (Glu) is the major excitatory neurotransmitter in the mammalian central
nervous system (CNS) where it is involved in the physiological regulation of different …

[HTML][HTML] Pharmacology of NMDA receptors

DT Monaghan, DE Jane - 2011 - europepmc.org
The discovery of NMDA receptors (NMDARs) was made possible by the synthesis and study
of NMDA (Figure 12.1) and various NMDAR antagonists by Jeff Watkins and colleagues [1] …

Synthesis, Spectroscopic Characterization, Cytotoxic Activity and Molecular Docking Studies of novel series of quinoxaline-2, 3-dione Derivatives

Y Seqqat, B Hafez, M Lahyaoui, F Toscano… - Moroccan Journal of …, 2024 - revues.imist.ma
Ce travail explore la synthèse de nouveaux dérivés basés sur l'échafaudage quinoxaline-2,
3-dione pour développer un nouveau dérivé de quinoxaline biologiquement actif. Ces …